v3.25.1
Revenue - Schedule of Revenue Disaggregated by Customer Type (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Disaggregation of Revenue [Line Items]    
Revenue [1] $ 20,605 $ 19,525
Pharma Tests and Services    
Disaggregation of Revenue [Line Items]    
Revenue 13,594 9,812
Enterprise Sales    
Disaggregation of Revenue [Line Items]    
Revenue 2,465 7,972
Population Sequencing    
Disaggregation of Revenue [Line Items]    
Revenue 4,213 1,500
Clinical diagnostic    
Disaggregation of Revenue [Line Items]    
Revenue 308 195
Other    
Disaggregation of Revenue [Line Items]    
Revenue $ 25 $ 46
[1] Includes related party revenue of $0.5 million for the three months ended March 31, 2025.